Thomas Andrew Davis - 31 Dec 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Thomas Davis
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$3,738
Form type
5
Filing time
16 Mar 2022, 17:29:45 UTC
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale $2,569 -948 -1.9% $2.71 49,224 02 Apr 2021 Direct F1
transaction GNCA Common Stock Sale $1,169 -524 -1.1% $2.23 48,700 01 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.